Form 8-K - Current report:
SEC Accession No. 0001104659-25-022763
Filing Date
2025-03-12
Accepted
2025-03-12 07:35:34
Documents
52
Period of Report
2025-03-12
Items
Item 2.02: Results of Operations and Financial Condition
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm258742d4_8k.htm   iXBRL 8-K 29328
2 EXHIBIT 99.1 tm258742d4_ex99-1.htm EX-99.1 69014
3 EXHIBIT 99.2 tm258742d4_ex99-2.htm EX-99.2 49703
7 GRAPHIC tm258742d4_ex99-1img001.jpg GRAPHIC 20240
8 GRAPHIC tm258742d4_ex99-2img001.jpg GRAPHIC 131180
9 GRAPHIC tm258742d4_ex99-2img002.jpg GRAPHIC 314515
10 GRAPHIC tm258742d4_ex99-2img003.jpg GRAPHIC 157271
11 GRAPHIC tm258742d4_ex99-2img004.jpg GRAPHIC 178300
12 GRAPHIC tm258742d4_ex99-2img005.jpg GRAPHIC 128903
13 GRAPHIC tm258742d4_ex99-2img006.jpg GRAPHIC 102393
14 GRAPHIC tm258742d4_ex99-2img007.jpg GRAPHIC 129205
15 GRAPHIC tm258742d4_ex99-2img008.jpg GRAPHIC 116086
16 GRAPHIC tm258742d4_ex99-2img009.jpg GRAPHIC 124033
17 GRAPHIC tm258742d4_ex99-2img010.jpg GRAPHIC 71119
18 GRAPHIC tm258742d4_ex99-2img011.jpg GRAPHIC 133792
19 GRAPHIC tm258742d4_ex99-2img012.jpg GRAPHIC 137905
20 GRAPHIC tm258742d4_ex99-2img013.jpg GRAPHIC 102494
21 GRAPHIC tm258742d4_ex99-2img014.jpg GRAPHIC 92923
22 GRAPHIC tm258742d4_ex99-2img015.jpg GRAPHIC 124222
23 GRAPHIC tm258742d4_ex99-2img016.jpg GRAPHIC 145453
24 GRAPHIC tm258742d4_ex99-2img017.jpg GRAPHIC 98437
25 GRAPHIC tm258742d4_ex99-2img018.jpg GRAPHIC 141369
26 GRAPHIC tm258742d4_ex99-2img019.jpg GRAPHIC 101875
27 GRAPHIC tm258742d4_ex99-2img020.jpg GRAPHIC 94959
28 GRAPHIC tm258742d4_ex99-2img021.jpg GRAPHIC 107086
29 GRAPHIC tm258742d4_ex99-2img022.jpg GRAPHIC 95403
30 GRAPHIC tm258742d4_ex99-2img023.jpg GRAPHIC 129251
31 GRAPHIC tm258742d4_ex99-2img024.jpg GRAPHIC 140980
32 GRAPHIC tm258742d4_ex99-2img025.jpg GRAPHIC 159574
33 GRAPHIC tm258742d4_ex99-2img026.jpg GRAPHIC 149210
34 GRAPHIC tm258742d4_ex99-2img027.jpg GRAPHIC 152447
35 GRAPHIC tm258742d4_ex99-2img028.jpg GRAPHIC 71393
36 GRAPHIC tm258742d4_ex99-2img029.jpg GRAPHIC 78154
37 GRAPHIC tm258742d4_ex99-2img030.jpg GRAPHIC 130758
38 GRAPHIC tm258742d4_ex99-2img031.jpg GRAPHIC 164510
39 GRAPHIC tm258742d4_ex99-2img032.jpg GRAPHIC 131846
40 GRAPHIC tm258742d4_ex99-2img033.jpg GRAPHIC 135886
41 GRAPHIC tm258742d4_ex99-2img034.jpg GRAPHIC 156107
42 GRAPHIC tm258742d4_ex99-2img035.jpg GRAPHIC 122677
43 GRAPHIC tm258742d4_ex99-2img036.jpg GRAPHIC 190251
  Complete submission text file 0001104659-25-022763.txt   6907171

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA sgmt-20250312.xsd EX-101.SCH 3012
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE sgmt-20250312_lab.xml EX-101.LAB 34240
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE sgmt-20250312_pre.xml EX-101.PRE 22357
54 EXTRACTED XBRL INSTANCE DOCUMENT tm258742d4_8k_htm.xml XML 3815
Mailing Address 155 BOVET RD., SUITE 303 SAN MATEO CA 94402
Business Address 155 BOVET RD., SUITE 303 SAN MATEO CA 94402 (650) 561-8600
Sagimet Biosciences Inc. (Filer) CIK: 0001400118 (see all company filings)

EIN.: 205991472 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41742 | Film No.: 25730004
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)